Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Reich who wrote (20798)	4/19/1999 12:59:00 PM
From: VLAD	Respond to of 23519

Look at PFE continue to tank. DOWN 6 1/2 points as I type. It's about time some of the fat gets trimmed off this pig! I bet the Chief Propaganda Officer over on the PFE thread is in a frenzy now attempting to spew out what a great value Pfizer is at $120/share. With a 1999 projected annual earnings of $2.45 that is a forward looking PE of 49! IMO still way over valuated by historic standard. Everyone always said that PFE deserved its higher valuation because of Viagra but it appears that Viagra is now a non issue. IMO a forward PE of 35 is still a rich valuation. That would give us a share price of $86.00/share. I doubt it will go that low unless the fundies decide to hedge their shares.